© РИА Томск. Павел Стефанский
TOMSK, Jul 16 – RIA Tomsk. Tomsk Polytechnic University (TPU) will start producing yttrium microspheres - a drug for the treatment of inoperable liver tumors, - at TPU Nuclear Research Reactor, the university's press service reported on Thursday.
According to the press service, TPU will manufacture the drug in cooperation with an industrial partner. Feature and advantage of yttrium microspheres is the targeted destruction of the tumor and the preservation of healthy organs and tissues.
"The production technology was developed by a Moscow organization, they are the holders of the registration certificate. We will organize contract production at the only research nuclear reactor beyond the Urals", - the press service quotes the head of the TPU radiopharmaceuticals production office Evgeniy Nesterov.
© предоставлено пресс-службой ТПУ
It is specified that the drug will be used to treat inoperable liver tumors. Unlike chemotherapy, which affects the entire body, microspheres act on the tumor in a targeted manner, since the drug enters the bloodstream. This allows the patient to live longer and improve the quality of life after therapy.
It is added that the TPU industrial partner is negotiating the supply of a radiopharmaceutical to leading Russian and European clinics that are interested in the method.
Tomsk Polytechnic University Nuclear Research Reactor - is the only operating university nuclear reactor in Russia. It was launched in 1967 and has been upgraded several times since then. The reactor conducts promising research in the field of environmental management and materials science, nuclear medicine. TPU is one of the leading Russian centers for the development and production of radiopharmaceuticals - drugs containing radioisotopes.